Net loss of Samrat Pharmachem reported to Rs 0.46 crore in the quarter ended December 2025 as against net profit of Rs 2.78 crore during the previous quarter ended December 2024. Sales declined 0.36% to Rs 63.43 crore in the quarter ended December 2025 as against Rs 63.66 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 63.43 | 63.66 | 0 |
| OPM % | -1.02 | 6.57 | - |
| PBDT | -0.38 | 4.08 | PL |
| PBT | -0.57 | 3.91 | PL |
| NP | -0.46 | 2.78 | PL |
Powered by Capital Market - Live News